Muhammad Morshed is a clinical microbiologist and the program head of zoonotic diseases, emerging pathogens and parasitology at the BCCDC Laboratory. He is also a clinical professor in the UBC Department of Pathology & Laboratory Medicine.
Dr. Morshed’s primary research area is medical microbiology, infectious diseases and immunopathology; his secondary research area is molecular pathology and cell biology, and zoonotic and spirochaetal diseases. His work includes a focus on modern diagnosis, the discovery of novel pathogens and the molecular epidemiology of zoonotic and emerging pathogens, particularly Borrelia burgdorferi, Treponema pallidum and Helicobacter pylori.
His laboratory at BCCDC is responsible for specialized serology testing, molecular testing and microbial fingerprinting, program evaluation and research. Currently, his team is working on developing in-house nucleic acid testing as well as finding novel pathogens for vector-borne diseases.
Dr. Morshed received his PhD from the Yamaguchi University School of Medicine (Japan) in 1994. He completed his specialty training at the Research Institute of Tuberculosis in Tokyo and at the College of Natural Resources, University of California (Berkeley).
Dr. Morshed is recognized by the national and international research community for his expertise on spirochaetal diseases. He is a member of many provincial, national and international working groups and networks in the area of zoonotic and emerging pathogens, and serves on the executive boards of the Canadian College of Microbiologists (CCM) and Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID). He received an Excellence in Clinical Services Award from the UBC Department of Pathology & Laboratory Medicine in 2016, was named a winner in the RBC Top 25 Canadian Immigrant Awards in 2017, received the Distinguished Microbiologist Award from the Canadian College of Microbiologists (CCM) in 2019 and became elected as an Expatriate Fellow by the Bangladesh Academy of Sciences (BAS) in 2020.
